key: cord-0953000-ah40duy7
authors: Ruiz, Emily Stamell; Veldhuizen, Inge J.; Abdullah, Aleisa; Rossi, Anthony; Nehal, Kishwer S.; Schmults, Chrysalyne; Waldman, Abigail; Lee, Erica H.
title: Impact of COVID-19 Delays on Skin Cancer Worry and Mohs Surgery for Keratinocytic Carcinoma
date: 2021-12-04
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2021.11.052
sha: 761012f1e844cb66c78f73525784c890d403a11f
doc_id: 953000
cord_uid: ah40duy7

nan

In March 2020, the National Comprehensive Cancer Network (NCCN) recommended delaying 37 treatment during the COVID-19 pandemic for keratinocyte carcinoma (KC) except for tumors 38 determined to pose a risk of "metastasis or debilitating progression within 3 months." 1 This study 39 sought to evaluate the impact of the COVID-19 pandemic on cancer worry in patients 40 Worry scale was similar in all patients (COVID-delay: 45.0 (SD 17.9) vs. controls: 44.7 (SD 63 44.7), p=.9). MANOVA found higher equivalent cancer worry scores in tumors ≥ 20mm (+7.9), 64 patients less than 65 years of age (+7.1), and female patients (+4.4). Table 2 (27) 14 (10) 49 (75) 18 (28) 4 (6) 72 (91) 20 (25) 10 (13) Did you develop any of the following symptoms after March 1, 2020? n (%) Cough Fever Sore throat Nasal congestion/runny nose Shortness of breath Muscle aches Anosmia 5 (4) 0 (0) 0 (0) 1 (1) 1 (1) 0 (0) 1 (1) 3 (3) 0 (0) 0 (0) 2 (2) 0 (0) 1 (1) 0 (0) 2 (3) 0 (0) 0 (0) 0 (0) 1 (1) 0 (0) 1 (1) History of COVID-19, n (%) 3 (2) 0 (0) 3 (4) Abbreviations: BWH, Brigham and Women's Hospital; MSKCC, Memorial Sloan Kettering Cancer Center

Comprehensive Cancer Network Covid-19 Resources: Advisory Statement for Non 81

Melanoma Skin Cancer Care During the Covid-19 Pandemic

FACE-Q Skin Cancer Module for 86 measuring patient-reported outcomes following facial skin cancer surgery

Patient experiences and 90 outcomes following facial skin cancer surgery: A qualitative study

A systematic review of patient-94 reported outcome instruments of nonmelanoma skin cancer in the dermatologic population